Peer Mentoring for Black and Latinx Teens with Type 1 Diabetes

Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Recruiting N/A Interventional Study
Type 1 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
13 – 21
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
38 (estimated)
Sponsor
Yale University · Other
Who this trial is looking for

This trial is looking for Black and Latinx adolescents with type 1 diabetes who want to learn how to use a device called continuous glucose monitor (CGM). Participants will join mentoring sessions to get support and improve their use of this device.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with type 1 diabetes.
  • I identify as Black and/or Latinx.
  • I can understand and communicate in written and spoken English.
  • I have access to a personal cellphone or tablet.
  • I have used CGM less than 50% of the time in the last 3 months.

You may not be able to join if

  • I have had a severe skin reaction to CGM sensor or adhesive.
  • I currently use a CGM.
  • I am currently pregnant or planning to become pregnant.
  • I cannot understand or communicate in spoken/written English.
  • I have other medical or mental health conditions that would interfere with the study.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adoles…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one diabetes-related auto-antibody * Self-identification as Black and/or Latinx. * Ability of participant to comprehend and communi…
Contacts

Stuart A Weinzimer, MD

877.925.3637

stuart.weinzimer@yale.edu

CONTACT

Robin Whittemore, PhD, APRN, FAAN

203-737-2351

robin.whittemore@yale.edu

CONTACT